Rita Nanda, MD, on Treating Triple-Negative Breast Cancer: An Expert Perspective

Posted: Wednesday, April 21, 2021

Rita Nanda, MD, of the University of Chicago, talks about the challenges facing clinicians who treat patients with triple-negative breast cancer, research on immunotherapy in combination with chemotherapy, and the high response rates in first-line therapy for those with advanced-stage disease.